-
Something wrong with this record ?
Incidence and severity of pertussis hospitalisations in infants aged less than 1 year in 37 hospitals of six EU/EEA countries, results of PERTINENT sentinel pilot surveillance system, December 2015 to December 2018
L. Merdrignac, F. Aït El Belghiti, E. Pandolfi, M. Jané, J. Murphy, K. Fabiánová, M. García Cenoz, E. Flem, S. Guillot, AE. Tozzi, G. Carmona, A. Habington, J. Zavadilová, A. Navasués, H. Bøås, D. Lévy-Brühl, B. Ferretti, M. Lanaspa, N....
Language English Country Sweden
Document type Case Reports, Journal Article, Observational Study
NLK
Directory of Open Access Journals
from 1996
Free Medical Journals
from 1995
Freely Accessible Science Journals
from 1995-09-01
PubMed Central
from 2016
Europe PubMed Central
from 2016
Open Access Digital Library
from 1996-01-01
Open Access Digital Library
from 2016-01-01
Medline Complete (EBSCOhost)
from 2010-07-01
ROAD: Directory of Open Access Scholarly Resources
from 1995
- MeSH
- Bordetella pertussis MeSH
- European Union MeSH
- Hospitalization MeSH
- Incidence MeSH
- Infant MeSH
- Humans MeSH
- Hospitals MeSH
- Infant, Newborn MeSH
- Whooping Cough * diagnosis epidemiology prevention & control MeSH
- Pertussis Vaccine MeSH
- Aged MeSH
- Vaccination MeSH
- Check Tag
- Infant MeSH
- Humans MeSH
- Male MeSH
- Infant, Newborn MeSH
- Aged MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Observational Study MeSH
- Geographicals
- Czech Republic MeSH
- Europe MeSH
- France MeSH
- Ireland MeSH
- Italy MeSH
- Norway MeSH
IntroductionPERTINENT is a pilot active surveillance system of infants hospitalised with pertussis in six European Union/European Economic Area countries (37 hospitals, seven sites).AimThis observational study aimed to estimate annual pertussis incidence per site from 2016 to 2018 and respective trends between 2017 and 2018. Pertussis cases were described, including their severity.MethodsWe developed a generic protocol and laboratory guidelines to harmonise practices across sites. Cases were hospitalised infants testing positive for Bordetella pertussis by PCR or culture. Sites collected demographic, clinical, laboratory data, vaccination status, and risk/protective factors. We estimated sites' annual incidences by dividing case numbers by the catchment populations.ResultsFrom December 2015 to December 2018, we identified 469 cases (247 males; 53%). The median age, birthweight and gestational age were 2.5 months (range: 0-11.6; interquartile range (IQR): 2.5), 3,280 g (range: 700-4,925; IQR: 720) and 39 weeks (range: 25-42; IQR: 2), respectively. Thirty cases (6%) had atypical presentation either with cough or cyanosis only or with absence of pertussis-like symptoms. Of 330 cases with information, 83 (25%) were admitted to intensive care units including five deceased infants too young to be vaccinated. Incidence rate ratios between 2018 and 2017 were 1.43 in Czech Republic (p = 0.468), 0.25 in Catalonia (p = 0.002), 0.71 in France (p = 0.034), 0.14 in Ireland (p = 0.002), 0.63 in Italy (p = 0.053), 0.21 in Navarra (p = 0.148) and zero in Norway.ConclusionsIncidence appeared to decrease between 2017 and 2018 in all but one site. Enhanced surveillance of hospitalised pertussis in Europe is essential to monitor pertussis epidemiology and disease burden.
Biodiversité et Epidémiologie des bactéries et pathogènes Institut Pasteur Paris France
Chief Innovation Unit and Clinical Trials Bambino Gesù Children Hospital Rome Italy
CIBER of Epidemiology and Public Health CIBERESP Barcelona Spain
Clinical Microbiology Service Complejo Hospitalario de Navarra Pamplona Spain
Direction des maladies infectieuses Santé Publique France Paris France
Epidemiological surveillance and response Public Health Agency of Catalonia Barcelona Spain
Epidemiology Department Epiconcept Paris France
European Centre for Diseases Prevention and Control Stockholm Sweden
Infectious Disease Epidemiology and Modeling Norwegian Institute of Public Health Oslo Norway
Instituto de Recerca Pediatrica Hospital Sant Joan de Deu Barcelona Spain
Instituto de Salud Pública de Navarra IdiSNA Navarre Institute for Health Research Pamplona Spain
Microbiology Our Lady's Children's hospital Crumlin Dublin Ireland
Multifactorial Disease and Complex Phenotype Research Area Bambino Gesù Children Hospital Rome Italy
National Institute of Public Health Prague Czech Republic
Research Temple Street Children's University Hospital Dublin Ireland
Sorbonne University INSERM Institut Pierre Louis d'Epidémiologie et de Santé Publique Paris France
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21019532
- 003
- CZ-PrNML
- 005
- 20210830101124.0
- 007
- ta
- 008
- 210728s2021 sw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2807/1560-7917.ES.2021.26.4.1900762 $2 doi
- 035 __
- $a (PubMed)33509338
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sw
- 100 1_
- $a Merdrignac, Lore $u Epidemiology Department, Epiconcept, Paris, France
- 245 10
- $a Incidence and severity of pertussis hospitalisations in infants aged less than 1 year in 37 hospitals of six EU/EEA countries, results of PERTINENT sentinel pilot surveillance system, December 2015 to December 2018 / $c L. Merdrignac, F. Aït El Belghiti, E. Pandolfi, M. Jané, J. Murphy, K. Fabiánová, M. García Cenoz, E. Flem, S. Guillot, AE. Tozzi, G. Carmona, A. Habington, J. Zavadilová, A. Navasués, H. Bøås, D. Lévy-Brühl, B. Ferretti, M. Lanaspa, N. O'Sullivan, P. Křížová, L. Fernandino, T. Bekkevold, T. Hanslik, C. Muñoz-Almagro, S. Bacci, G. Spiteri, M. Valenciano, A. Moren, PERTINENT Group, PERTINENT group
- 520 9_
- $a IntroductionPERTINENT is a pilot active surveillance system of infants hospitalised with pertussis in six European Union/European Economic Area countries (37 hospitals, seven sites).AimThis observational study aimed to estimate annual pertussis incidence per site from 2016 to 2018 and respective trends between 2017 and 2018. Pertussis cases were described, including their severity.MethodsWe developed a generic protocol and laboratory guidelines to harmonise practices across sites. Cases were hospitalised infants testing positive for Bordetella pertussis by PCR or culture. Sites collected demographic, clinical, laboratory data, vaccination status, and risk/protective factors. We estimated sites' annual incidences by dividing case numbers by the catchment populations.ResultsFrom December 2015 to December 2018, we identified 469 cases (247 males; 53%). The median age, birthweight and gestational age were 2.5 months (range: 0-11.6; interquartile range (IQR): 2.5), 3,280 g (range: 700-4,925; IQR: 720) and 39 weeks (range: 25-42; IQR: 2), respectively. Thirty cases (6%) had atypical presentation either with cough or cyanosis only or with absence of pertussis-like symptoms. Of 330 cases with information, 83 (25%) were admitted to intensive care units including five deceased infants too young to be vaccinated. Incidence rate ratios between 2018 and 2017 were 1.43 in Czech Republic (p = 0.468), 0.25 in Catalonia (p = 0.002), 0.71 in France (p = 0.034), 0.14 in Ireland (p = 0.002), 0.63 in Italy (p = 0.053), 0.21 in Navarra (p = 0.148) and zero in Norway.ConclusionsIncidence appeared to decrease between 2017 and 2018 in all but one site. Enhanced surveillance of hospitalised pertussis in Europe is essential to monitor pertussis epidemiology and disease burden.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a Bordetella pertussis $7 D001886
- 650 _2
- $a Evropská unie $7 D005062
- 650 _2
- $a hospitalizace $7 D006760
- 650 _2
- $a nemocnice $7 D006761
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a incidence $7 D015994
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a novorozenec $7 D007231
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a pertusová vakcína $7 D010567
- 650 _2
- $a vakcinace $7 D014611
- 650 12
- $a pertuse $x diagnóza $x epidemiologie $x prevence a kontrola $7 D014917
- 651 _2
- $a Česká republika $7 D018153
- 651 _2
- $a Evropa $7 D005060
- 651 _2
- $a Francie $7 D005602
- 651 _2
- $a Irsko $7 D007494
- 651 _2
- $a Itálie $7 D007558
- 651 _2
- $a Norsko $7 D009664
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a pozorovací studie $7 D064888
- 700 1_
- $a Aït El Belghiti, Fatima $u Direction des maladies infectieuses, Santé Publique France, Paris, France
- 700 1_
- $a Pandolfi, Elisabetta $u Multifactorial Disease and Complex Phenotype Research Area, Bambino Gesù Children Hospital, Rome, Italy
- 700 1_
- $a Jané, Mireia $u Epidemiological surveillance and response, Public Health Agency of Catalonia, Barcelona, Spain
- 700 1_
- $a Murphy, Jane $u Research, Temple Street Children's University Hospital, Dublin, Ireland
- 700 1_
- $a Fabiánová, Kateřina $u National Institute of Public Health, Prague, Czech Republic
- 700 1_
- $a García Cenoz, Manuel $u Instituto de Salud Pública de Navarra, IdiSNA - Navarre Institute for Health Research, Pamplona, Spain
- 700 1_
- $a Flem, Elmira $u Infectious Disease Epidemiology and Modeling, Norwegian Institute of Public Health, Oslo, Norway
- 700 1_
- $a Guillot, Sophie $u Biodiversité et Epidémiologie des bactéries et pathogènes, Institut Pasteur, Paris, France
- 700 1_
- $a Tozzi, Alberto E $u Chief Innovation Unit and Clinical Trials, Bambino Gesù Children Hospital, Rome, Italy
- 700 1_
- $a Carmona, Gloria $u Epidemiological surveillance and response, Public Health Agency of Catalonia, Barcelona, Spain
- 700 1_
- $a Habington, Adele $u Microbiology, Our Lady's Children's hospital Crumlin, Dublin, Ireland
- 700 1_
- $a Zavadilová, Jana $u National Institute of Public Health, Prague, Czech Republic
- 700 1_
- $a Navasués, Ana $u Clinical Microbiology Service, Complejo Hospitalario de Navarra, Pamplona, Spain
- 700 1_
- $a Bøås, Håkon $u Infectious Disease Epidemiology and Modeling, Norwegian Institute of Public Health, Oslo, Norway
- 700 1_
- $a Lévy-Brühl, Daniel $u Direction des maladies infectieuses, Santé Publique France, Paris, France
- 700 1_
- $a Ferretti, Beatrice $u Multifactorial Disease and Complex Phenotype Research Area, Bambino Gesù Children Hospital, Rome, Italy
- 700 1_
- $a Lanaspa, Miguel $u Instituto de Recerca Pediatrica Hospital Sant Joan de Deu, Barcelona, Spain
- 700 1_
- $a O'Sullivan, Niam $u Microbiology, Our Lady's Children's hospital Crumlin, Dublin, Ireland
- 700 1_
- $a Křížová, Pavla $u National Institute of Public Health, Prague, Czech Republic
- 700 1_
- $a Fernandino, Leticia $u Instituto de Salud Pública de Navarra, IdiSNA - Navarre Institute for Health Research, Pamplona, Spain
- 700 1_
- $a Bekkevold, Terese $u Infectious Disease Epidemiology and Modeling, Norwegian Institute of Public Health, Oslo, Norway
- 700 1_
- $a Hanslik, Thomas $u Sorbonne University, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France
- 700 1_
- $a Muñoz-Almagro, Carmen $u CIBER of Epidemiology and Public Health CIBERESP, Barcelona, Spain $u Universitat Internacional de Catalunya, Barcelona, Spain $u Instituto de Recerca Pediatrica Hospital Sant Joan de Deu, Barcelona, Spain
- 700 1_
- $a Bacci, Sabrina $u European Centre for Diseases Prevention and Control, Stockholm, Sweden
- 700 1_
- $a Spiteri, Gianfranco $u European Centre for Diseases Prevention and Control, Stockholm, Sweden
- 700 1_
- $a Valenciano, Marta $u Epidemiology Department, Epiconcept, Paris, France
- 700 1_
- $a Moren, Alain $u Epidemiology Department, Epiconcept, Paris, France
- 710 2_
- $a PERTINENT Group
- 710 2_
- $a PERTINENT group
- 773 0_
- $w MED00174364 $t Euro surveillance : bulletin Europeen sur les maladies transmissibles European communicable disease bulletin $x 1560-7917 $g Roč. 26, č. 4 (2021)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33509338 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830101124 $b ABA008
- 999 __
- $a ok $b bmc $g 1690374 $s 1139978
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 26 $c 4 $e - $i 1560-7917 $m Euro surveillance $n Euro Surveill $x MED00174364
- LZP __
- $a Pubmed-20210728